CALA logo

Calithera Biosciences (CALA) Selling, General & Administrative Expenses

Annual SGA

$13.54 M
-$7.31 M-35.06%

December 31, 2022

Summary

Performance

1-Year Change

-35.06%

3-Year Change

-18.45%

5-Year Change

+8.07%

15-Year Change

+8.07%

CALA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.92%
CALA annual SGA is higher than 30.92% of companies in Healthcare sector

High & Low

All-time High

$20.85 M
CALA annual SGA is currently -35.06% below its historical high of $20.85 million

3-Year Low

$13.54 M
CALA annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CALA previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CALA next annual earnings announcement has not yet been scheduled

OtherCALAexpensesmetrics:

Annual Total Expenses

$42.07 M
CALA annual total expenses is $42.07 million

Annual Operating Expenses

$42.07 M
CALA annual total operating expenses is $42.07 million

Annual Cost Of Goods Sold

-
CALA annual cost of goods sold value is unknown

Annual Interest Expense

-
CALA annual interest expense value is unknown

Quarterly SGA

$2.58 M
-$495.00 K-16.08%

December 31, 2022

Summary

Performance

3-Month Change

-16.08%

1-Year Change

-39.34%

3-Year Change

-43.22%

5-Year Change

-21.7%

CALA Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.67%
CALA quarterly SGA is higher than 21.67% of companies in Healthcare sector

High & Low

All-time High

$6.34 M
CALA quarterly SGA is currently -59.27% below its historical high of $6.34 million

3-Year Low

$2.58 M
CALA quarterly SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
CALA previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
CALA next earnings announcement has not yet been scheduled

OtherCALAexpensesmetrics:

Quarterly Total Expenses

$7.35 M
CALA quarterly total expenses is $7.35 million

Quarterly Operating Expenses

$7.35 M
CALA quarterly total operating expenses is $7.35 million

Quarterly Cost Of Goods Sold

-
CALA quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
CALA quarterly interest expense value is unknown

TTM SGA

-$2.02 B
-$21.29 M-1.07%

December 31, 2022

Summary

Performance

3-Month Change

-13085.24%

1-Year Change

-10358.24%

3-Year Change

-12261.01%

5-Year Change

-12261.01%

CALA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.3%
CALA TTM SGA is higher than 24.3% of companies in Healthcare sector

High & Low

All-time High

-$30.14 M

3-Year Low

-$2.02 B
CALA TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
CALA previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
CALA next earnings announcement has not yet been scheduled

OtherCALAexpensesmetrics:

Annual Total Expenses

$42.07 M
CALA annual total expenses is $42.07 million

Annual Operating Expenses

$42.07 M
CALA annual total operating expenses is $42.07 million

TTM Cost Of Goods Sold

-
CALA TTM cost of goods sold value is unknown

TTM Interest Expense

-
CALA TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$13.54 M
CALA annual SGA is $13.54 million

Annual Operating Expenses

$42.07 M
CALA annual total operating expenses is $42.07 million

Annual Cost Of Goods Sold

-
CALA annual cost of goods sold value is unknown

CALA Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.1%-39.3%-10000.0%
3 y3 years-18.4%-43.2%-10000.0%
5 y5 years+8.1%-21.7%-10000.0%

CALA Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.1%at low-43.8%at low-17.3%at low
5 y5-year-35.1%at low-59.3%at low-99.0%at low
alltimeall time-35.1%+855.6%-59.3%+343.2%-6599.4%at low

Calithera Biosciences Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2022
$13.54 M(-35.1%)
$2.58 M(-16.1%)
$13.54 M(-12.9%)
Sep 2022
-
$3.08 M(-14.9%)
$15.55 M(-17.4%)
Jun 2022
-
$3.62 M(-15.1%)
$18.82 M(-4.4%)
Mar 2022
-
$4.26 M(-7.3%)
$19.68 M(-5.6%)
Dec 2021
$20.85 M(+2.4%)
$4.59 M(-27.6%)
$20.85 M(-4.5%)
Sep 2021
-
$6.34 M(+41.4%)
$21.84 M(+7.9%)
Jun 2021
-
$4.49 M(-17.3%)
$20.25 M(-2.9%)
Mar 2021
-
$5.43 M(-2.8%)
$20.85 M(+2.4%)
Dec 2020
$20.37 M(+22.7%)
$5.59 M(+17.7%)
$20.37 M(+5.4%)
Sep 2020
-
$4.74 M(-6.9%)
$19.34 M(+4.5%)
Jun 2020
-
$5.10 M(+3.0%)
$18.50 M(+6.4%)
Mar 2020
-
$4.95 M(+8.7%)
$17.39 M(+4.7%)
Dec 2019
$16.61 M(+24.5%)
$4.55 M(+16.5%)
$16.61 M(+8.5%)
Sep 2019
-
$3.91 M(-2.0%)
$15.30 M(+5.7%)
Jun 2019
-
$3.98 M(-4.3%)
$14.48 M(+3.5%)
Mar 2019
-
$4.16 M(+28.2%)
$14.00 M(+4.9%)
Dec 2018
$13.34 M
$3.25 M(+5.2%)
$13.34 M(-0.4%)
Sep 2018
-
$3.09 M(-11.7%)
$13.39 M(+0.1%)
Jun 2018
-
$3.50 M(-0.3%)
$13.38 M(+5.1%)
DateAnnualQuarterlyTTM
Mar 2018
-
$3.51 M(+6.3%)
$12.73 M(+1.6%)
Dec 2017
$12.53 M(+18.4%)
$3.30 M(+7.4%)
$12.53 M(+2.4%)
Sep 2017
-
$3.07 M(+7.9%)
$12.24 M(+6.6%)
Jun 2017
-
$2.85 M(-13.9%)
$11.49 M(+1.6%)
Mar 2017
-
$3.31 M(+9.9%)
$11.30 M(+6.8%)
Dec 2016
$10.59 M(+16.7%)
$3.01 M(+29.8%)
$10.59 M(+7.3%)
Sep 2016
-
$2.32 M(-13.0%)
$9.87 M(+1.2%)
Jun 2016
-
$2.67 M(+2.9%)
$9.75 M(+3.4%)
Mar 2016
-
$2.59 M(+12.9%)
$9.43 M(+3.9%)
Dec 2015
$9.07 M(+69.4%)
$2.29 M(+4.4%)
$9.07 M(+5.0%)
Sep 2015
-
$2.20 M(-6.1%)
$8.64 M(+10.9%)
Jun 2015
-
$2.34 M(+4.6%)
$7.79 M(+15.3%)
Mar 2015
-
$2.24 M(+19.9%)
$6.76 M(+26.2%)
Dec 2014
$5.35 M(+116.1%)
$1.87 M(+38.5%)
$5.35 M(+19.5%)
Sep 2014
-
$1.35 M(+2.9%)
$4.48 M(+20.6%)
Jun 2014
-
$1.31 M(+57.3%)
$3.72 M(+54.4%)
Mar 2014
-
$832.00 K(-16.1%)
$2.41 M(+52.8%)
Dec 2013
$2.48 M(+74.9%)
$992.00 K(+70.2%)
$1.57 M(+170.2%)
Sep 2013
-
$583.00 K
$583.00 K
Dec 2012
$1.42 M
-
-

FAQ

  • What is Calithera Biosciences annual SGA?
  • What is the all time high annual SGA for Calithera Biosciences?
  • What is Calithera Biosciences annual SGA year-on-year change?
  • What is Calithera Biosciences quarterly SGA?
  • What is the all time high quarterly SGA for Calithera Biosciences?
  • What is Calithera Biosciences quarterly SGA year-on-year change?
  • What is Calithera Biosciences TTM SGA?
  • What is the all time high TTM SGA for Calithera Biosciences?
  • What is Calithera Biosciences TTM SGA year-on-year change?

What is Calithera Biosciences annual SGA?

The current annual SGA of CALA is $13.54 M

What is the all time high annual SGA for Calithera Biosciences?

Calithera Biosciences all-time high annual SGA is $20.85 M

What is Calithera Biosciences annual SGA year-on-year change?

Over the past year, CALA annual SGA has changed by -$7.31 M (-35.06%)

What is Calithera Biosciences quarterly SGA?

The current quarterly SGA of CALA is $2.58 M

What is the all time high quarterly SGA for Calithera Biosciences?

Calithera Biosciences all-time high quarterly SGA is $6.34 M

What is Calithera Biosciences quarterly SGA year-on-year change?

Over the past year, CALA quarterly SGA has changed by -$1.68 M (-39.34%)

What is Calithera Biosciences TTM SGA?

The current TTM SGA of CALA is -$2.02 B

What is the all time high TTM SGA for Calithera Biosciences?

Calithera Biosciences all-time high TTM SGA is -$30.14 M

What is Calithera Biosciences TTM SGA year-on-year change?

Over the past year, CALA TTM SGA has changed by -$2.04 B (-10358.24%)